Deutsche Bank Aktiengesellschaft Reiterates Buy Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "buy" rating reiterated by equities research analysts at Deutsche Bank Aktiengesellschaft in a report issued on Wednesday, Marketbeat.com reports. They currently have a GBX 275 ($3.69) target price on the stock. Deutsche Bank Aktiengesellschaft's price objective points to a potential upside of 31.26% from the company's current price.

Separately, Berenberg Bank restated a "buy" rating and issued a GBX 300 ($4.03) price target on shares of Advanced Medical Solutions Group in a report on Tuesday.

Advanced Medical Solutions Group Price Performance

Advanced Medical Solutions Group stock traded up GBX 2.50 ($0.03) on Wednesday, reaching GBX 209.50 ($2.81). The company's stock had a trading volume of 319,715 shares, compared to its average volume of 918,995. The company has a debt-to-equity ratio of 37.01, a quick ratio of 4.58 and a current ratio of 8.39. Advanced Medical Solutions Group has a twelve month low of GBX 168.40 ($2.26) and a twelve month high of GBX 275.83 ($3.70). The company has a market cap of £452.37 million, a price-to-earnings ratio of 40.60, a PEG ratio of 5.00 and a beta of 0.74. The business's fifty day moving average price is GBX 204.93 and its 200 day moving average price is GBX 204.60.

Insider Buying and Selling

In other news, insider Eddie Johnson sold 115,206 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of GBX 195 ($2.62), for a total transaction of £224,651.70 ($301,545.91). Also, insider A Christopher (Chris) Meredith sold 211,521 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of GBX 194 ($2.60), for a total value of £410,350.74 ($550,806.36). In the last quarter, insiders have sold 435,255 shares of company stock worth $84,691,330. 3.12% of the stock is owned by corporate insiders.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.